Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lowered its position in Option Care Health, Inc. (NASDAQ:OPCH) by 47.4% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,271,662 shares of the company’s stock after selling 1,146,436 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Option Care Health were worth $44,445,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Option Care Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after purchasing an additional 75,313 shares in the last quarter. Wellington Management Group LLP grew its position in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock worth $425,143,000 after buying an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP grew its position in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company’s stock worth $92,518,000 after buying an additional 591,042 shares during the period. Northern Trust Corp increased its position in shares of Option Care Health by 11.8% in the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company’s stock valued at $60,934,000 after buying an additional 278,158 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Option Care Health during the fourth quarter valued at $60,219,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 1.5%

NASDAQ:OPCH opened at $29.94 on Friday. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The stock has a market cap of $4.90 billion, a price-to-earnings ratio of 24.15, a PEG ratio of 1.84 and a beta of 0.73. The stock has a 50-day moving average price of $31.62 and a two-hundred day moving average price of $31.57.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.26 billion. During the same period in the prior year, the firm posted $0.26 earnings per share. The business’s quarterly revenue was up 16.3% compared to the same quarter last year. As a group, equities analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, JMP Securities reissued a “market outperform” rating and issued a $36.00 price target on shares of Option Care Health in a research note on Wednesday, June 18th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.